Cardiology Pharmacists: Expanding Roles in Modern Heart Care

Cardiovascular disease continues to be a leading cause of illness and death globally, and in Singapore specifically, an aging population and increasing metabolic risk factors are driving demand for more comprehensive, long-term cardiac care. Within this evolving landscape, the role of cardiology pharmacists is undergoing a significant transformation, extending beyond traditional dispensing functions to encompass direct patient care, medication optimization, and collaborative practice with physicians.

A recent position paper developed by the Pharmaceutical Society of Singapore Cardiology Pharmacy Working Group highlights both the essential contributions of these specialists and the challenges hindering their full potential. The paper, published in the Annals of the Academy of Medicine, Singapore in November 2025, emphasizes the need for a more robust and integrated approach to cardiology pharmacy practice.

The Expanding Scope of Cardiology Pharmacy

Traditionally, pharmacists have been vital in ensuring the accurate and safe dispensing of medications. But, cardiology pharmacists are now increasingly involved in a broader range of activities. These include optimizing medication regimens to improve patient outcomes, managing transitions of care – particularly crucial moments like hospital discharge – and providing comprehensive patient education to enhance adherence and understanding of treatment plans. This work spans various settings, from hospitals and ambulatory clinics to community pharmacies. Board of Pharmacy Specialties offers a certification (BCCP) for pharmacists specializing in cardiovascular disease.

The position paper underscores that cardiology pharmacists are particularly valuable in ensuring medication safety, supporting patient adherence, and implementing protocol-guided dose optimization – all under the supervision of a physician. This collaborative model, often described as “physician-led, pharmacist-enabled,” is seen as key to sustainable cardiovascular care.

Challenges to Scalable Delivery in Singapore

Despite the recognized benefits, the paper identifies several key obstacles to expanding the role of cardiology pharmacists in Singapore. A primary concern is the limited number of specialist accreditation pathways. This restricts the pipeline of qualified professionals, hindering the capacity to meet national needs and achieve guideline-directed therapy targets. Uneven distribution of services across the country also presents a challenge, creating disparities in access to specialized care.

Emerging digital health technologies, even as offering potential solutions, also introduce fresh complexities. Successful implementation of telehealth and other digital tools requires careful consideration of infrastructure, training, and patient access. The position paper notes that these challenges are occurring against a backdrop of rising demand for longitudinal cardiovascular care.

Five Priorities for the Future

To address these challenges and maximize the contributions of cardiology pharmacists, the Pharmaceutical Society of Singapore Cardiology Pharmacy Working Group has endorsed five key priorities:

1. Strengthening Specialist Workforce Capability: Expanding accreditation pathways and investing in training programs to increase the number of qualified cardiology pharmacists.
2. Enhancing Early Post-Discharge Reviews: Improving follow-up care after hospital discharge to prevent readmissions and ensure continuity of care. This is a particularly critical period for medication reconciliation and adherence.
3. Integrating Pharmacists Across Care Settings: Breaking down silos between hospitals, primary care physicians, and community pharmacies to create a more seamless and coordinated system of care.
4. Leveraging Digital-Enabled Care: Utilizing telehealth and other digital tools to expand access to care, improve patient engagement, and enhance medication management.
5. Expanding Medication-Focused Roles: Broadening the scope of practice for cardiology pharmacists to include prevention, management of atrial fibrillation, palliative care for heart failure, and precision medicine approaches.

The Global Trend: Redefining the Pharmacist’s Role

The evolution of cardiology pharmacy practice in Singapore mirrors a broader global trend. Pharmacy Times reports that cardiology pharmacists are increasingly taking on more direct patient care responsibilities in many countries. This shift is driven by several factors, including the growing complexity of cardiovascular medications, the need for improved medication adherence, and the increasing emphasis on team-based care.

This expanded role requires pharmacists to develop specialized knowledge and skills in areas such as advanced cardiac life support, interpretation of electrocardiograms, and management of complex medication regimens. It also necessitates strong communication and collaboration skills to effectively work with physicians, nurses, and other healthcare professionals.

What Comes Next: A Process of Continuous Improvement

The recommendations outlined in the position paper are not a one-time fix, but rather a starting point for ongoing evaluation and refinement. The Pharmaceutical Society of Singapore Cardiology Pharmacy Working Group will continue to monitor the implementation of these priorities and assess their impact on patient outcomes. Further research is needed to identify best practices and address remaining challenges.

Regular reviews of national guidelines and protocols will be essential to ensure that they reflect the latest evidence and incorporate the evolving role of cardiology pharmacists. Collaboration with stakeholders across the healthcare system – including physicians, nurses, policymakers, and patient advocacy groups – will be crucial to achieving sustainable improvements in cardiovascular care. The ongoing development of digital health solutions will also require careful monitoring and evaluation to ensure their effectiveness and accessibility.

the goal is to create a healthcare system that leverages the expertise of cardiology pharmacists to optimize medication apply, improve patient outcomes, and reduce the burden of cardiovascular disease in Singapore and beyond.